Your browser doesn't support javascript.
loading
The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review.
Kohlhoff, Georgia; Kirwan, Richard; Mushtaq, Sohail.
Afiliación
  • Kohlhoff G; Faculty of Medicine, Dentistry and Life Sciences, University of Chester, Chester, UK.
  • Kirwan R; Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK. r.p.kirwan@ljmu.ac.uk.
  • Mushtaq S; Faculty of Medicine, Dentistry and Life Sciences, University of Chester, Chester, UK.
Eur J Nutr ; 63(8): 2859-2869, 2024 Dec.
Article en En | MEDLINE | ID: mdl-39276209
ABSTRACT

BACKGROUND:

Insulin resistance (IR) is a common pathology in women with polycystic ovarian syndrome (PCOS) involved in increased rates of cardiometabolic disease such as diabetes and cardiovascular disease. Low serum vitamin D is often associated with insulin resistance but there is no consensus on whether vitamin D supplementation can ameliorate markers of IR in PCOS.

OBJECTIVES:

We assessed evidence on the effects of vitamin D supplementation (≥ 1000 IU/day), without the use of additional supplements or other pharmacological treatments known to affect IR, on markers of IR and glycemic control in women with PCOS.

DESIGN:

A systematic search was conducted using PubMed, Medline and Web of Science databases from January 2000 up to November 2023. Randomized controlled trials that assessed the effects of vitamin D supplementation in women with PCOS, on fasting glucose, fasting insulin, glycated haemoglobin (HbA1c) or homeostatic model assessment for insulin resistance (HOMA-IR) were included.

RESULTS:

9 studies were identified. Study populations ranged from 28 to 180 participants, with mean ages ranging from 22 to 30 years. Daily vitamin D doses ranged from 1714-12,000 IU. Of the included studies, 3 reported statistically significant reductions in fasting glucose, 2 reported reductions in fasting insulin, 2 reported reductions in HOMA-IR, none reported reductions in HbA1c and 5 reported no differences in any of the relevant outcomes.

CONCLUSIONS:

In conclusion, in RCTs of vitamin D supplementation in women with PCOS, the majority of studies do not report statistically significant improvements in fasting glucose, fasting insulin, HbA1c or HOMA-IR. However, as a minority of studies report some statistically significant results, further investigation may be warranted. REGISTRY PROSPERO ID CRD42023486144.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Vitamina D / Resistencia a la Insulina / Biomarcadores / Suplementos Dietéticos Límite: Adult / Female / Humans Idioma: En Revista: Eur J Nutr Asunto de la revista: CIENCIAS DA NUTRICAO Año: 2024 Tipo del documento: Article Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Vitamina D / Resistencia a la Insulina / Biomarcadores / Suplementos Dietéticos Límite: Adult / Female / Humans Idioma: En Revista: Eur J Nutr Asunto de la revista: CIENCIAS DA NUTRICAO Año: 2024 Tipo del documento: Article Pais de publicación: Alemania